World’s Only Approved Total Artificial Heart

The SynCardia temporary Total Artificial Heart is the first and only FDA, Health Canada and CE approved Total Artificial Heart in the world. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for patients dying from end-stage biventricular heart failure.

INTERMACS Data

25+ Years of Clinical Use:

10-year pivotal clinical study ›› FDA SSE

79% bridge-to-transplant rate ›› NEJM

INTERMACS ›› INTERMACS Data

Compare to BiVADs ›› STS Abstract

RV dysfunction & failure ›› Article Index

Professional papers ›› Article Index